India widens QR-code drug tracking to vaccines, antibiotics and anti-cancer medicines

The Health Ministry has expanded its track-and-trace framework so that vaccines, antimicrobials, narcotic drugs and anti-cancer medicines must now carry a QR or barcode — letting patients and regulators authenticate them and fight fakes.

What happened

• The Ministry of Health and Family Welfare notified amendments to the Drugs Rules, 1945 to expand the ambit of Schedule H2 and bring additional drug categories under the QR-code-based track-and-trace framework.
• Under the amended provisions, all vaccines, antimicrobials, narcotic and psychotropic drugs (under the NDPS Act, 1985) and all anti-cancer drugs are now included under Schedule H2.
• Schedule H2 provides for affixing a Bar Code or Quick Response (QR) Code on the packaging of specified drugs to facilitate authentication and traceability across the supply chain.
• Manufacturers must print or affix the code on the primary packaging label — or, where space is inadequate, on the secondary packaging label.
• The move strengthens the quality, safety and integrity of India's pharmaceutical supply chain and helps tackle counterfeit and substandard medicines.

For Prelims

• Schedule H2 (track and trace): A schedule of the Drugs Rules, 1945 mandating a barcode/QR code on specified drug packaging for authentication and traceability. It earlier covered the top ~300 drug brands (from 2023); this expansion adds vaccines, antimicrobials, NDPS drugs and anti-cancer drugs.
• Why it matters: QR codes let patients/regulators verify a medicine's authenticity (manufacturer, batch, expiry) by scanning — countering counterfeit, spurious and substandard drugs and improving recall.
• Antimicrobial resistance (AMR): Bringing antimicrobials under traceability supports AMR control and quality assurance of antibiotics — a public-health priority.
• NDPS Act, 1985: Governs narcotic and psychotropic substances; tracking such drugs aids both quality control and diversion prevention.
• Regulators: The Drugs and Cosmetics Act, 1940 and Rules, 1945 are administered by the CDSCO (central, under DCGI) and state drug controllers.
• Primary vs secondary packaging: 'Primary' packaging directly contacts the drug (strip/bottle); 'secondary' is the outer carton — the rule prefers the primary label, with secondary as a fallback.
• Don't confuse: Schedule H2 (barcode/QR traceability) is distinct from Schedule H/H1 (prescription drugs) and Schedule X (narcotics retail) — different regulatory purposes under the same Rules.

For Mains

Syllabus: GS2.13 · GS2.9 · Linkage L1